Bio-Rad Laboratories Inc (BIO NYSE) stock market data APIs
$310.612
2.08(0.7%)
as of December 15, 2025
Try our APIs with
free plan!
Bio-Rad Laboratories Inc Financial Data Overview
Price chart is built with
Anychart
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Prev. Close
310.612
Open
312.692
High
313.5947
Low
300.1519
52 wk Range
211.43-373.69
Market Cap
8 306 M
Shares Outstanding
21 906 K
Revenue
2 557 M
EPS
2.26
Beta
1.187
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Bio-Rad Laboratories Inc (top by weight)
Ticker
100-day Price Change
Weight
EAASX.US
EATON VANCE ATLANTA CAPITAL SMID-CAP FUND EATON VANCE ATLANTA CAPITAL SMID-CAP FUND CLASS A
-3.66
(-10.71%)
3.08
GMVM.F
VanEck Vectors UCITS ETFs plc - VanEck Vectors Morningstar US Wide Moat UCITS ETF
2.52
(4.81%)
2.86
MDEV.US
First Trust Exchange-Traded Fund VI - First Trust Indxx Medical Devices ETF
0.4
(1.92%)
1.95
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bio-Rad Laboratories Inc data using free add-ons & libraries
Get Bio-Rad Laboratories Inc Fundamental Data
Bio-Rad Laboratories Inc Fundamental data includes:
- Net Revenue: 2 557 M
- EBITDA: 418 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-30
- EPS/Forecast: 1.94
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bio-Rad Laboratories Inc News
New
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity
Company Logo The blood collection tubes market presents opportunities through innovation in automated systems, advanced materials, and digital traceability to enhance workflow efficiency and complian...
Bio-Rad, Poly Medicure, and Sekisui Medical Power Rapid Expansion in the Venous Blood Collection Market Through 2032
Company Logo The venous blood collection market is poised for growth, driven by innovations in sampling technology and increasing demand due to chronic disease prevalence. Opportunities lie in automa...
In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides
Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situ...
A Look At The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)
Key Insights The projected fair value for Bio-Rad Laboratories is US$394 based on 2 Stage Free Cash Flow to Equity With US$325 share price, Bio-Rad Laboratories appears to be trading close to its est...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
